Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.

Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C.

J Clin Invest. 2007 Nov;117(11):3248-57.

2.

How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow.

Gregory CA, Gunn WG, Reyes E, Smolarz AJ, Munoz J, Spees JL, Prockop DJ.

Ann N Y Acad Sci. 2005 May;1049:97-106. Review.

PMID:
15965110
3.

The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells.

Park JR, Jung JW, Lee YS, Kang KS.

Cell Prolif. 2008 Dec;41(6):859-74. doi: 10.1111/j.1365-2184.2008.00565.x.

PMID:
19040566
4.

Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling.

Qiao L, Xu ZL, Zhao TJ, Ye LH, Zhang XD.

Cancer Lett. 2008 Sep 28;269(1):67-77. doi: 10.1016/j.canlet.2008.04.032. Epub 2008 Jun 20.

PMID:
18571836
5.

Rough surface topography enhances the activation of Wnt/β-catenin signaling in mesenchymal cells.

Galli C, Passeri G, Ravanetti F, Elezi E, Pedrazzoni M, Macaluso GM.

J Biomed Mater Res A. 2010 Dec 1;95(3):682-90. doi: 10.1002/jbm.a.32887.

PMID:
20725985
6.

Wnt signaling controls the fate of mesenchymal stem cells.

Ling L, Nurcombe V, Cool SM.

Gene. 2009 Mar 15;433(1-2):1-7. doi: 10.1016/j.gene.2008.12.008. Epub 2008 Dec 24. Review.

PMID:
19135507
7.

Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.

Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole S, Nusse R, Sylvester KG.

Gastroenterology. 2007 Nov;133(5):1579-91. Epub 2007 Aug 28.

PMID:
17983805
8.

Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling.

Zhou H, Mak W, Zheng Y, Dunstan CR, Seibel MJ.

J Biol Chem. 2008 Jan 25;283(4):1936-45. Epub 2007 Nov 28.

9.

Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.

Chen G, A J, Wang M, Farley S, Lee LY, Lee LC, Sawicki MP.

Mol Cancer Res. 2008 Dec;6(12):1894-907. doi: 10.1158/1541-7786.MCR-07-2206.

10.

Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.

Pu P, Zhang Z, Kang C, Jiang R, Jia Z, Wang G, Jiang H.

Cancer Gene Ther. 2009 Apr;16(4):351-61. doi: 10.1038/cgt.2008.78. Epub 2008 Oct 24.

PMID:
18949017
11.

Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model.

Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC, Ye L, Zhang X.

Cell Res. 2008 Apr;18(4):500-7. doi: 10.1038/cr.2008.40.

12.

Down-regulation of Wnt signaling could promote bone marrow-derived mesenchymal stem cells to differentiate into hepatocytes.

Ke Z, Zhou F, Wang L, Chen S, Liu F, Fan X, Tang F, Liu D, Zhao G.

Biochem Biophys Res Commun. 2008 Mar 7;367(2):342-8. doi: 10.1016/j.bbrc.2007.12.134. Epub 2008 Jan 2.

PMID:
18174024
13.

A role of Wnt/beta-catenin signals in hepatic fate specification of human umbilical cord blood-derived mesenchymal stem cells.

Yoshida Y, Shimomura T, Sakabe T, Ishii K, Gonda K, Matsuoka S, Watanabe Y, Takubo K, Tsuchiya H, Hoshikawa Y, Kurimasa A, Hisatome I, Uyama T, Terai M, Umezawa A, Shiota G.

Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1089-98. Epub 2007 Sep 20.

14.

Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.

Martinez G, Wijesinghe M, Turner K, Abud HE, Taketo MM, Noda T, Robinson ML, de Iongh RU.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4794-806. doi: 10.1167/iovs.09-3567. Epub 2009 Jun 10.

PMID:
19515997
15.

Wnt signaling inhibits cementoblast differentiation and promotes proliferation.

Nemoto E, Koshikawa Y, Kanaya S, Tsuchiya M, Tamura M, Somerman MJ, Shimauchi H.

Bone. 2009 May;44(5):805-12. doi: 10.1016/j.bone.2008.12.029. Epub 2009 Jan 14.

PMID:
19442631
16.

The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner.

Yano F, Kugimiya F, Ohba S, Ikeda T, Chikuda H, Ogasawara T, Ogata N, Takato T, Nakamura K, Kawaguchi H, Chung UI.

Biochem Biophys Res Commun. 2005 Aug 12;333(4):1300-8.

PMID:
15979579
17.

The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche.

Aicher A, Kollet O, Heeschen C, Liebner S, Urbich C, Ihling C, Orlandi A, Lapidot T, Zeiher AM, Dimmeler S.

Circ Res. 2008 Oct 10;103(8):796-803. doi: 10.1161/CIRCRESAHA.107.172718. Epub 2008 Sep 5.

18.

Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.

Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.

Transl Res. 2007 Nov;150(5):281-94. Epub 2007 Jul 18.

PMID:
17964517
19.

Wnt signaling pathway in mammary gland development and carcinogenesis.

Turashvili G, Bouchal J, Burkadze G, Kolar Z.

Pathobiology. 2006;73(5):213-23. Review.

PMID:
17314492
20.

Wnt signaling and its downstream target N-myc regulate basal progenitors in the developing neocortex.

Kuwahara A, Hirabayashi Y, Knoepfler PS, Taketo MM, Sakai J, Kodama T, Gotoh Y.

Development. 2010 Apr;137(7):1035-44. doi: 10.1242/dev.046417.

Supplemental Content

Support Center